Skip to main content
Premium Trial:

Request an Annual Quote

BioImage Validates Cell-based Assay Tech with Evotec

SAN FRANCISCO, Jan. 28 (GenomeWeb News) - Danish drug-discovery firm BioImage and Evotec Technologies have co-validated BioImage's cell-based assay technology on Evotec's line of high-content screening instruments, the companies said this week.


Interviewed at Cambridge Healthtech Institutes' High-Content Analysis conference, held here this week, the firms said they have validated BioImage's Redistribution fluorescent assays for protein translocation on Evotec's Opera confocal-based high-content screening instrument.


Company officials at the meeting said BioImage has now made available full application notes for researchers wishing to apply Redistribution assays on an Opera system. This is the third major high-content instrument platform on which BioImage has validated its assays. The other two platforms are GE Healthcare's IN Cell Analyzer and Cellomics' ArrayScan.


The agreement, which has not been formally announced by either company, caps a busy week for BioImage. As reported last week by Inside Bioassays, a GenomeWeb News sister publication, BioImage was expected to announce an agreement to license Redistribution to an undisclosed top-10 pharmaceutical company. This week, BioImage revealed that the company is Boehringer Ingelheim, which has been granted full use of the Redistribution assays in its drug-discovery programs.


In addition, earlier this week BioImage and German biotech RNAx said that they had penned a partnership to provide RNAx's RNAi-knockdown technology as a complement the Redistribution assays for drug-discovery and other cell biology applications.


Financial terms of the deals were not disclosed.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.